RIDDHI SHAH: Open Payments
NPI 1730722430 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 84 payments from 14 companies in 2025. Trend: 2023 $134 · 2024 $882 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $384 |
| ABBVIE INC. | 26 | $328 |
| Boston Scientific Corporation | 8 | $177 |
| Collegium Pharmaceutical, Inc. | 11 | $149 |
| PFIZER INC. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Averitas Pharma Inc. | 2 | $37 |
| SPR Therapeutics, Inc | 1 | $27 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| Bioventus LLC | 1 | $22 |
Products named: RELISTOR, FARAPULSE, UBRELVY, QULIPTA, Belbuca, NURTEC ODT, AUSTEDO XR, QUTENZA.
Industry payments across PA — which companies pay providers there.
